2007
DOI: 10.1002/mds.21583
|View full text |Cite
|
Sign up to set email alerts
|

Hiccup secondary to dopamine agonists in Parkinson's Disease

Abstract: Hiccup is produced by a sudden contraction of the inspiratory muscles followed by an abrupt closure of the glottis, which produces the typical sound that characterizes this disorder. The causes of hiccup are diverse, 1 including several drugs. 2 Here, we report two cases of patients with Parkinson's Disease (PD) who developed hiccup after using different dopamine agonists (DAs). CLINICAL CASES Case 1This 76-year-old man with a history of arterial hypertension, acute myocardial infarction (AMI) in 1988, and hyp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(15 citation statements)
references
References 7 publications
0
15
0
Order By: Relevance
“…inducing hiccups (Miyaoka and Kamijima, 1999;Cheng et al, 2011). • Reports of dopaminergic agonists (amantadine, apomorphine, pergolide, pramipexole, piribedil, levodopa, ropinrole) used to treat hiccup (Welsh, 1904;Garrick, 1917;Askenasy et al, 1988;Martinez-Ruiz et al, 2004;Sharma et al, 2006;Lester et al, 2007;Gerschlager and Bloem, 2009;Coletti Moja, 2010). • Reports of failure of selective anti-dopaminergic agents (haloperidol) to control hiccups (Nishikawa et al, 2015).…”
Section: Evidence Against Dopaminergic Involvementmentioning
confidence: 99%
“…inducing hiccups (Miyaoka and Kamijima, 1999;Cheng et al, 2011). • Reports of dopaminergic agonists (amantadine, apomorphine, pergolide, pramipexole, piribedil, levodopa, ropinrole) used to treat hiccup (Welsh, 1904;Garrick, 1917;Askenasy et al, 1988;Martinez-Ruiz et al, 2004;Sharma et al, 2006;Lester et al, 2007;Gerschlager and Bloem, 2009;Coletti Moja, 2010). • Reports of failure of selective anti-dopaminergic agents (haloperidol) to control hiccups (Nishikawa et al, 2015).…”
Section: Evidence Against Dopaminergic Involvementmentioning
confidence: 99%
“…Replacement therapy with dopamine agonists in PD patients is considered to induce certain episodes of hiccup; however, in others, hiccup may occur as the non-motor symptom of PD rather than as side effect of anti-PD treatment 48. The pathogenesis is believed to be related to the fact that dopamine agonists share a high affinity for D 3 receptors which may be involved in the hiccup reflex arc 49. Hence, the drugs to block dopaminergic neurotransmission including chlorpromazine and metoclopramide may be employed in treating hiccup episodes 48.…”
Section: Etiology Of Persistent and Intractable Hiccupsmentioning
confidence: 99%
“…Persistent hiccups have been linked to drug-related causes, including chemotherapies and anesthetics, as well as many other conditions, such as nervous system disease, infection, and metabolic disorders 5,6. Pharmacologic approaches including baclofen, gabapentin, chlorpromazine, haloperidol, metoclopramide, lidocaine, valproic acid, and nifedipine, have been used with varying degrees of effectiveness7,8 but have not proved consistently effective 9–11.…”
Section: Introductionmentioning
confidence: 99%